Donisi Health Takes Home First Place in the Prestigious Innovations in Cardiovascular Intervention Competition
Summary
MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Wins the 2021 ICI Pitch Competition and $200,000 Award TEL AVIV, Israel, Dec. 8, 2021 /PRNewswire/ -- Donisi Health (Donisi) prevailed in this years ICI Innovation Competition – the premier international conference for innovations in cardiovascular intervention. Competing against startups from all over the world in front of a panel of twenty industry expert judges, Donisi took home First Place honors and a $200,000 award for their innovative solution to enable in-home monitoring for key health bio-markers for patients with Congestive Heart Failure (CHF) and other chronic diseases. Based upon FDA-cleared technology and backed by 11 granted patents, Donisis AI-based system detects and analyzes multiple health bio-indicators simultaneously - without the need to remove clothing or connect the patient to wires or patches - delivering clinically meaningful insights and notifications of changes in key health indicators. "We are honored to be recognized by this prestigious institution, and are grateful to the ICI team for highlighting our breakthrough technologys potential to meaningfully improve cardiovascular health," said Donisis CEO Yair Brosh. "It is known that when heart failure exacerbations are detected early, and healthcare teams intervene while patients are still at home before their condition worsens, many of these costly readmissions can be avoided, resulting in significant cost reduction and improved quality of life."
Classifications
AskAI Classifications
LabelsLinked Companies
